Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Name: Eulerpool
Brand: Eulerpool Research Systems
Availability: InStock
Rating: 4,9 (755 reviews)

Subscribe for $2

Overview

Profile

Daan Gene Co stock price, quote, forecast and news
stock price, forecast, news, chart, split, dividend and analysis Daan Gene Co ariva, Daan Gene Co onvista, Daan Gene Co finanzen.net, Daan Gene Co aktienfinder, Daan Gene Co marketscreener, Daan Gene Co marketwatch, Daan Gene Co bloomberg, Daan Gene Co handelsblatt, Daan Gene Co wiwo, Daan Gene Co forum

002030.SZ

CNE000001KP1

Currency:

Price

5.33

Today +/-

+0.02

Today %

+3.63 %

Ticker
002030.SZ

ISIN
CNE000001KP1

Daan Gene Co stock price

Weekly

Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Daan Gene Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Daan Gene Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Daan Gene Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Daan Gene Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Daan Gene Co Stock Price History

Date	Daan Gene Co Price
9/9/2024	5.33 undefined
9/6/2024	5.14 undefined
9/5/2024	5.21 undefined
9/4/2024	5.14 undefined
9/3/2024	5.22 undefined
9/2/2024	5.34 undefined
8/30/2024	5.39 undefined
8/29/2024	5.31 undefined
8/28/2024	5.34 undefined
8/27/2024	5.55 undefined
8/26/2024	5.38 undefined
8/23/2024	5.54 undefined
8/22/2024	5.96 undefined
8/21/2024	6.30 undefined
8/20/2024	6.49 undefined
8/19/2024	6.09 undefined
8/16/2024	6.44 undefined
8/15/2024	6.10 undefined
8/14/2024	6.01 undefined
8/13/2024	6.33 undefined
8/12/2024	5.94 undefined

Daan Gene Co Revenue, EBIT, Net Income CNE000001KP1 ·

3 years
5 years
10 years
25 Years
Max

Revenue

EBIT

Net Income

Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Daan Gene Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Daan Gene Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Daan Gene Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Daan Gene Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Daan Gene Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Daan Gene Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Daan Gene Co’s growth potential.

Daan Gene Co Revenue, EBIT and net profit per share

Date	Daan Gene Co Revenue	Daan Gene Co EBIT	Daan Gene Co Net Income
2023	1.18 B undefined	-277.64 M undefined	104.66 M undefined
2022	12.05 B undefined	6.2 B undefined	5.41 B undefined
2021	7.66 B undefined	3.95 B undefined	3.62 B undefined
2020	5.34 B undefined	2.54 B undefined	2.45 B undefined
2019	1.1 B undefined	-43.5 M undefined	92.2 M undefined
2018	1.48 B undefined	112.7 M undefined	101.6 M undefined
2017	1.54 B undefined	125.1 M undefined	86.4 M undefined
2016	1.61 B undefined	121.4 M undefined	106.7 M undefined
2015	1.47 B undefined	101.5 M undefined	101.2 M undefined
2014	1.09 B undefined	104 M undefined	153.1 M undefined
2013	854.4 M undefined	92.6 M undefined	133.3 M undefined
2012	582.7 M undefined	32.2 M undefined	90.2 M undefined
2011	457.6 M undefined	50 M undefined	68 M undefined
2010	370 M undefined	46 M undefined	56.5 M undefined
2009	319.6 M undefined	45.7 M undefined	47.4 M undefined
2008	239.2 M undefined	34 M undefined	34.9 M undefined
2007	207.3 M undefined	40.8 M undefined	35 M undefined
2006	172.7 M undefined	34.5 M undefined	28.7 M undefined
2005	162.5 M undefined	31.2 M undefined	26.3 M undefined
2004	155.9 M undefined	32.2 M undefined	25.2 M undefined

	Revenue	EBIT	Net Income
2004	155.9 M CNY	32.2 M CNY	25.2 M CNY
2005	162.5 M CNY	31.2 M CNY	26.3 M CNY
2006	172.7 M CNY	34.5 M CNY	28.7 M CNY
2007	207.3 M CNY	40.8 M CNY	35 M CNY
2008	239.2 M CNY	34 M CNY	34.9 M CNY
2009	319.6 M CNY	45.7 M CNY	47.4 M CNY
2010	370 M CNY	46 M CNY	56.5 M CNY
2011	457.6 M CNY	50 M CNY	68 M CNY
2012	582.7 M CNY	32.2 M CNY	90.2 M CNY
2013	854.4 M CNY	92.6 M CNY	133.3 M CNY
2014	1.09 B CNY	104 M CNY	153.1 M CNY
2015	1.47 B CNY	101.5 M CNY	101.2 M CNY
2016	1.61 B CNY	121.4 M CNY	106.7 M CNY
2017	1.54 B CNY	125.1 M CNY	86.4 M CNY
2018	1.48 B CNY	112.7 M CNY	101.6 M CNY
2019	1.1 B CNY	-43.5 M CNY	92.2 M CNY
2020	5.34 B CNY	2.54 B CNY	2.45 B CNY
2021	7.66 B CNY	3.95 B CNY	3.62 B CNY
2022	12.05 B CNY	6.2 B CNY	5.41 B CNY
2023	1.18 B CNY	-277.64 M CNY	104.66 M CNY

Daan Gene Co Income Statement, Balance Sheet, Cash Flow Statement

Simple
Expanded

Income Statement
Balance Sheet
Cashflow

REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIVIDEND ()DIV. ()DIVIDEND GROWTH (%)DIV. GROWTH (%)SHARES (B)DOCUMENTS

2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.07	0.1	0.13	0.16	0.16	0.17	0.21	0.24	0.32	0.37	0.46	0.58	0.85	1.09	1.47	1.61	1.54	1.48	1.1	5.34	7.66	12.05	1.18
-	41.67	29.41	17.42	4.52	6.17	20.35	15.46	33.47	15.99	23.51	27.35	46.74	27.17	35.73	9.36	-4.34	-4.15	-25.71	386.43	43.49	57.18	-90.20
37.50	36.27	41.67	53.55	53.70	56.98	57.97	61.92	56.74	58.92	54.70	55.33	48.95	41.80	37.58	43.42	43.13	41.61	49.82	70.75	74.63	70.80	35.00
0.03	0.04	0.06	0.08	0.09	0.1	0.12	0.15	0.18	0.22	0.25	0.32	0.42	0.45	0.55	0.7	0.67	0.62	0.55	3.78	5.72	8.53	0.41
0.02	0.02	0.03	0.03	0.03	0.03	0.04	0.03	0.05	0.05	0.05	0.03	0.09	0.1	0.1	0.12	0.13	0.11	-0.04	2.54	3.95	6.2	-0.28
25.00	22.55	21.97	20.65	19.14	19.77	19.32	14.23	14.11	12.43	10.94	5.50	10.77	9.58	6.85	7.51	8.11	7.58	-3.92	47.46	51.58	51.46	-23.47
0.01	0.02	0.02	0.03	0.03	0.03	0.04	0.03	0.05	0.06	0.07	0.09	0.13	0.15	0.1	0.11	0.09	0.1	0.09	2.45	3.62	5.41	0.1
-	28.57	27.78	8.70	4.00	7.69	25.00	-2.86	38.24	19.15	21.43	32.35	47.78	15.04	-33.99	4.95	-18.87	17.44	-8.91	2,561.96	47.73	49.59	-98.08
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.58	0.77	1.03	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Details

Keystats

ⓘ

Revenue and Growth

The Daan Gene Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Daan Gene Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT ASSETS (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-TERM INVESTMENTS (B)LONG-T. INVEST. (B)LONG-TERM RECEIVABLES (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)OTHER EQUITY (M)UNREALIZED GAINS/LOSSES (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (B)OTHER SHORT-TERM LIABILITIES (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)SHORT-TERM DEBTS (M)SHORT-TERM PORTION OF LONG-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM RECEIVABLES (B)SHORT-TERM REC. (B)LONG-TERM LIABILITIES (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIABILITIES (M)OTHER LIAB. (M)LONG-TERM LIABILITIES (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)

2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.02	0.02	0.02	0.13	0.1	0.07	0.02	0.08	0.07	0.09	0.07	0.07	0.11	0.17	1.16	1.46	1.26	0.39	0.27	1.76	2.55	3.56	2.39
0.01	0.03	0.04	0.06	0.08	0.1	0.12	0.14	0.15	0.17	0.22	0.28	0.43	0.55	0.7	0.84	0.94	0.69	0.71	1.5	2.26	4.07	2.06
1.3	1.2	3.3	5.8	11.7	22.5	32.4	34.2	27	25.5	27.9	33.5	44.4	102.3	107.9	89.3	742.7	619.7	335.7	390.8	277.11	452.14	353.87
1.4	10.3	8.7	20	9.5	12.1	26.1	35.5	45	50.4	66.6	76.4	99.2	142	155.5	217.8	203.2	161.3	185	315.7	493.72	369.6	239.52
3	3.8	13.9	4.3	8.2	8.1	6.1	14.6	25.5	43.8	29.4	26.7	51.6	79.6	161	463.1	57.5	260.1	252.7	367	408.59	321.38	269.34
0.04	0.06	0.09	0.22	0.21	0.2	0.21	0.31	0.32	0.38	0.42	0.49	0.73	1.04	2.29	3.06	3.21	2.11	1.75	4.33	5.98	8.77	5.31
0.06	0.07	0.09	0.09	0.09	0.11	0.15	0.15	0.16	0.16	0.17	0.19	0.21	0.23	0.31	0.42	0.56	0.31	0.29	0.49	1.05	1.85	2.52
0	0	0	0	0	0	0	0.01	0.02	0.04	0.07	0.11	0.08	0.17	0.25	0.39	0.48	0.9	0.98	1.37	2.72	3.09	1.95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.7	8.8	52.6	46.9	207.1	73.5	17.24	72.39	52.1
0.7	0.6	0	0	0	9.2	55	58.4	65.8	69.2	84.9	83.3	90.8	110.9	143.6	205.5	269.4	213.9	260	308.8	396.89	738.96	892.89
0	0	0	0	0	0	4.2	4.2	4.2	4.2	4.2	4.2	4.2	4.2	6	6	6	6	6	0	0	0	0
0	0	2.5	0	0	3.3	2.6	3.7	13.2	22.7	32.6	37.7	38.3	37.6	39.5	47.1	65.3	69.4	76.3	132.6	162.35	239.42	286.18
0.06	0.07	0.09	0.09	0.09	0.12	0.22	0.22	0.26	0.3	0.37	0.43	0.43	0.55	0.75	1.08	1.44	1.55	1.81	2.37	4.35	5.99	5.71
0.1	0.13	0.18	0.31	0.3	0.33	0.43	0.53	0.59	0.67	0.79	0.91	1.16	1.59	3.04	4.14	4.64	3.66	3.56	6.7	10.34	14.76	11.02

0.03	0.05	0.06	0.08	0.08	0.13	0.13	0.2	0.24	0.29	0.35	0.42	0.46	0.55	0.66	0.72	0.72	0.8	0.8	0.88	1.4	1.4	1.4
0.8	0.8	1.1	127.8	126	85	93	47	47	47.7	24.1	24.6	24.6	21.8	423.5	612.6	631.5	682.2	674.6	674	621.38	719.99	651.54
0.01	0.02	0.03	0.04	0.06	0.07	0.09	0.08	0.08	0.08	0.12	0.13	0.22	0.28	0.24	0.27	0.32	0.33	0.37	2.72	5.33	9.18	6.83
0	0	0	0	0	0	0	0	-0.1	-0.1	0	-0.1	-0.2	-0.2	-0.2	2.8	0.8	2.3	2.4	0.9	0.5	-2.85	-3.92
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.05	0.07	0.09	0.26	0.27	0.28	0.31	0.33	0.37	0.42	0.49	0.57	0.7	0.85	1.33	1.61	1.68	1.82	1.84	4.27	7.35	11.3	8.88
1.4	3.9	5.4	4.3	5.5	13.8	11	19.5	31.5	34.9	40.8	60.5	79.7	157.1	218.1	181	205	109.2	128.5	474.9	553.01	737.07	425.44
0	0	0	0	0	0.01	0.02	0.01	0.02	0.04	0.01	0.02	0.03	0.03	0.04	0.07	0.05	0.05	0.06	0.53	0.99	1.56	0.76
10.2	10.2	12	2.7	3.9	12.7	15.2	3.9	10.9	13.4	74.8	49.8	128.4	95.9	155.1	112.2	398.4	242.5	148.4	584.6	584.11	426.34	127.1
15	20	35	35	0	0	68.1	70	90	80	85	140	145	361.2	660.9	945.7	865	725.5	723.4	286.5	347.81	197.89	390.81
0	0	15	0	0	0	0	0	0	0	0	0	0	0	0	20	66.3	256.7	54.3	184.6	45.32	45.18	15.51
0.03	0.04	0.07	0.05	0.01	0.03	0.11	0.1	0.15	0.17	0.21	0.27	0.38	0.64	1.07	1.33	1.59	1.38	1.12	2.06	2.52	2.97	1.72
15	15	0	0	0	0	0	30	0	0	0	0	0	0	0	200	354.1	54.4	293.8	13.2	78.32	73.35	27.11
0	0	0	0	0	0	0	0	0	0	1.2	1.2	1.2	3.5	3.5	4.3	4.5	4.3	37.3	60.7	46.97	47.97	79.85
4.1	10.9	14.7	10.9	13.6	12	6.4	13.8	9	25.2	20.7	17.4	16.9	29.9	29.4	55.5	51.9	24.5	27.3	47	30.14	51.11	32.8
19.1	25.9	14.7	10.9	13.6	12	6.4	43.8	9	25.2	21.9	18.6	18.1	33.4	32.9	259.8	410.5	83.2	358.4	120.9	155.43	172.42	139.76
0.05	0.06	0.08	0.06	0.03	0.05	0.12	0.14	0.16	0.19	0.23	0.29	0.4	0.68	1.1	1.59	2	1.46	1.47	2.19	2.68	3.14	1.86
0.1	0.13	0.18	0.31	0.3	0.32	0.42	0.47	0.53	0.61	0.72	0.86	1.1	1.53	2.43	3.2	3.68	3.28	3.32	6.45	10.03	14.44	10.74

Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Daan Gene Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Daan Gene Co's financial health and stability.

Assets

Daan Gene Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Daan Gene Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Daan Gene Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Daan Gene Co's financial standing, aiding in investment evaluations and risk assessments.

Daan Gene Co stock margins CNE000001KP1 ·

The Daan Gene Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Daan Gene Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Daan Gene Co.

3 years
5 years
10 years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Daan Gene Co's sales revenue. A higher gross margin percentage indicates that the Daan Gene Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Daan Gene Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Daan Gene Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Daan Gene Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Daan Gene Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Daan Gene Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Daan Gene Co Margin History

Daan Gene Co Gross margin	Daan Gene Co Profit margin	Daan Gene Co EBIT margin	Daan Gene Co Profit margin
2023	35.04 %	-23.51 %	8.86 %
2022	70.8 %	51.47 %	44.93 %
2021	74.64 %	51.58 %	47.21 %
2020	70.75 %	47.47 %	45.85 %
2019	49.82 %	-3.96 %	8.4 %
2018	41.61 %	7.62 %	6.87 %
2017	43.14 %	8.11 %	5.6 %
2016	43.43 %	7.53 %	6.62 %
2015	37.63 %	6.88 %	6.86 %
2014	41.88 %	9.57 %	14.1 %
2013	48.92 %	10.84 %	15.6 %
2012	55.41 %	5.53 %	15.48 %
2011	54.79 %	10.93 %	14.86 %
2010	58.97 %	12.43 %	15.27 %
2009	56.88 %	14.3 %	14.83 %
2008	61.87 %	14.21 %	14.59 %
2007	58.08 %	19.68 %	16.88 %
2006	57.09 %	19.98 %	16.62 %
2005	53.91 %	19.2 %	16.18 %
2004	53.56 %	20.65 %	16.16 %

	Gross margin	EBIT margin	Profit margin
2004	53.56 %	20.65 %	16.16 %
2005	53.91 %	19.2 %	16.18 %
2006	57.09 %	19.98 %	16.62 %
2007	58.08 %	19.68 %	16.88 %
2008	61.87 %	14.21 %	14.59 %
2009	56.88 %	14.3 %	14.83 %
2010	58.97 %	12.43 %	15.27 %
2011	54.79 %	10.93 %	14.86 %
2012	55.41 %	5.53 %	15.48 %
2013	48.92 %	10.84 %	15.6 %
2014	41.88 %	9.57 %	14.1 %
2015	37.63 %	6.88 %	6.86 %
2016	43.43 %	7.53 %	6.62 %
2017	43.14 %	8.11 %	5.6 %
2018	41.61 %	7.62 %	6.87 %
2019	49.82 %	-3.96 %	8.4 %
2020	70.75 %	47.47 %	45.85 %
2021	74.64 %	51.58 %	47.21 %
2022	70.8 %	51.47 %	44.93 %
2023	35.04 %	-23.51 %	8.86 %

Daan Gene Co Stock Sales Revenue, EBIT, Earnings per Share CNE000001KP1 ·

The Daan Gene Co earnings per share therefore indicates how much revenue Daan Gene Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 years
5 years
10 years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Daan Gene Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Daan Gene Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Daan Gene Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Daan Gene Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Daan Gene Co Revenue, EBIT and net profit per share

Date	Daan Gene Co Sales per Share	Daan Gene Co EBIT per share	Daan Gene Co Earnings per Share
2023	0.84 undefined	-0.2 undefined	0.07 undefined
2022	8.58 undefined	4.42 undefined	3.86 undefined
2021	5.46 undefined	2.82 undefined	2.58 undefined
2020	3.81 undefined	1.81 undefined	1.75 undefined
2019	0.78 undefined	-0.03 undefined	0.07 undefined
2018	1.05 undefined	0.08 undefined	0.07 undefined
2017	1.1 undefined	0.09 undefined	0.06 undefined
2016	1.15 undefined	0.09 undefined	0.08 undefined
2015	1.05 undefined	0.07 undefined	0.07 undefined
2014	0.77 undefined	0.07 undefined	0.11 undefined
2013	0.61 undefined	0.07 undefined	0.09 undefined
2012	0.42 undefined	0.02 undefined	0.06 undefined
2011	0.33 undefined	0.04 undefined	0.05 undefined
2010	0.26 undefined	0.03 undefined	0.04 undefined
2009	0.23 undefined	0.03 undefined	0.03 undefined
2008	0.17 undefined	0.02 undefined	0.02 undefined
2007	0.15 undefined	0.03 undefined	0.02 undefined
2006	0.12 undefined	0.02 undefined	0.02 undefined
2005	0.12 undefined	0.02 undefined	0.02 undefined
2004	0.11 undefined	0.02 undefined	0.02 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	0.11 CNY	0.02 CNY	0.02 CNY
2005	0.12 CNY	0.02 CNY	0.02 CNY
2006	0.12 CNY	0.02 CNY	0.02 CNY
2007	0.15 CNY	0.03 CNY	0.02 CNY
2008	0.17 CNY	0.02 CNY	0.02 CNY
2009	0.23 CNY	0.03 CNY	0.03 CNY
2010	0.26 CNY	0.03 CNY	0.04 CNY
2011	0.33 CNY	0.04 CNY	0.05 CNY
2012	0.42 CNY	0.02 CNY	0.06 CNY
2013	0.61 CNY	0.07 CNY	0.09 CNY
2014	0.77 CNY	0.07 CNY	0.11 CNY
2015	1.05 CNY	0.07 CNY	0.07 CNY
2016	1.15 CNY	0.09 CNY	0.08 CNY
2017	1.1 CNY	0.09 CNY	0.06 CNY
2018	1.05 CNY	0.08 CNY	0.07 CNY
2019	0.78 CNY	-0.03 CNY	0.07 CNY
2020	3.81 CNY	1.81 CNY	1.75 CNY
2021	5.46 CNY	2.82 CNY	2.58 CNY
2022	8.58 CNY	4.42 CNY	3.86 CNY
2023	0.84 CNY	-0.2 CNY	0.07 CNY

Daan Gene Co business model

Daan Gene Co is one of the most popular companies on Eulerpool.com.

Daan Gene Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Daan Gene Co historical P/E ratio, EBIT, and P/S ratio.

Daan Gene Co shares outstanding CNE000001KP1 ·

The number of shares was Daan Gene Co in 2023 — This indicates how many shares 1.403 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 years
5 years
10 years
25 Years
Max

Number of stocks

Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

	Number of stocks
2004	1.4 B Aktien
2005	1.4 B Aktien
2006	1.4 B Aktien
2007	1.4 B Aktien
2008	1.4 B Aktien
2009	1.4 B Aktien
2010	1.4 B Aktien
2011	1.4 B Aktien
2012	1.4 B Aktien
2013	1.4 B Aktien
2014	1.4 B Aktien
2015	1.4 B Aktien
2016	1.4 B Aktien
2017	1.4 B Aktien
2018	1.4 B Aktien
2019	1.4 B Aktien
2020	1.4 B Aktien
2021	1.4 B Aktien
2022	1.4 B Aktien
2023	1.4 B Aktien

Daan Gene Co Stock splits

In Daan Gene Co's history, there have been no stock splits.

Daan Gene Co dividend history and estimates CNE000001KP1 ·

In 2023, Daan Gene Co paid a dividend amounting to 1.75 CNY. Dividend means that Daan Gene Co distributes a portion of its profits to its owners.

3 years
5 years
10 years
25 Years
Max

Dividend

Dividend (Estimate)

Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Daan Gene Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Daan Gene Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Daan Gene Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Daan Gene Co Dividend History

Date	Daan Gene Co Dividend
2023	1.75 undefined
2022	1.11 undefined
2021	0.34 undefined
2020	0.01 undefined
2019	0.02 undefined
2018	0.01 undefined
2017	0.02 undefined
2016	0.01 undefined
2015	0.02 undefined
2014	0.01 undefined
2013	0 undefined
2012	0.01 undefined
2011	0 undefined
2010	0.01 undefined
2009	0 undefined
2008	0.01 undefined
2007	0.01 undefined
2006	0.02 undefined
2005	0.01 undefined

	Dividend	Dividend (Estimate)
2004	0 CNY	0 CNY
2005	0.01 CNY	0 CNY
2006	0.02 CNY	0 CNY
2007	0.01 CNY	0 CNY
2008	0.01 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0.01 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0.01 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0.01 CNY	0 CNY
2015	0.02 CNY	0 CNY
2016	0.01 CNY	0 CNY
2017	0.02 CNY	0 CNY
2018	0.01 CNY	0 CNY
2019	0.02 CNY	0 CNY
2020	0.01 CNY	0 CNY
2021	0.34 CNY	0 CNY
2022	1.11 CNY	0 CNY
2023	1.75 CNY	0 CNY

Daan Gene Co dividend payout ratio CNE000001KP1 ·

In 2023, Daan Gene Co had a payout ratio of 14.31%. The payout ratio indicates the percentage of the company's profits that Daan Gene Co distributes as dividends.

3 years
5 years
10 years
25 Years
Max

Payout ratio

Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Daan Gene Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Daan Gene Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Daan Gene Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Daan Gene Co Payout Ratio History

Date	Daan Gene Co Payout ratio
2023	14.31 %
2022	28.78 %
2021	13.33 %
2020	0.81 %
2019	33.29 %
2018	18.43 %
2017	38.67 %
2016	14.63 %
2015	28 %
2014	6.82 %
2013	4 %
2012	9.83 %
2011	5 %
2010	12.75 %
2009	15 %
2008	69.5 %
2007	64.5 %
2006	89.5 %
2005	53.5 %
2004	14.31 %

	Payout ratio
2004	14.31 %
2005	53.5 %
2006	89.5 %
2007	64.5 %
2008	69.5 %
2009	15 %
2010	12.75 %
2011	5 %
2012	9.83 %
2013	4 %
2014	6.82 %
2015	28 %
2016	14.63 %
2017	38.67 %
2018	18.43 %
2019	33.29 %
2020	0.81 %
2021	13.33 %
2022	28.78 %
2023	14.31 %

Unfortunately, there are currently no price targets and forecasts available for Daan Gene Co.

Daan Gene Co latest earnings and earnings surprises

Date	EPS Estimate	EPS Actual	Quarterly report
9/30/2013	0.02	0.04 (47.61 %)	2013 Q3
6/30/2013	0.03	0.02 (-36.46 %)	2013 Q2
12/31/2012	0.02	0.02 (33.87 %)	2012 Q4
9/30/2012	0.01	0.01 (18.56 %)	2012 Q3
6/30/2012	0.02	0.02 (-29.58 %)	2012 Q2
12/31/2011	0.01	0.01 (4.3 %)	2011 Q4
9/30/2011	0.01	0.01 (14.82 %)	2011 Q3
6/30/2011	0.02	0.01 (-31.53 %)	2011 Q2
12/31/2010	0.01	0.01 (-19.72 %)	2010 Q4
9/30/2010	0.01	0.01 (9.47 %)	2010 Q3
12/31/2009	0.01	0.01 (-9.55 %)	2009 Q4
6/30/2009	0.01	0.01 (11.06 %)	2009 Q2
3/31/2009	0.01	0.01 (-2.41 %)	2009 Q1

Eulerpool ESG Scorecard© for the Daan Gene Co stock

Eulerpool World ESG Rating (EESG©)

43/ 100

🌱 Environment

👫 Social

🏛️ Governance

Environment

Scope 1 - Direct Emissions	—
Scope 2 - Indirect emissions from purchased energy	—
Scope 3 - Indirect emissions within the value chain	—
Total CO₂ emissions	—
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	❌
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	❌
Environmentally friendly packaging	❌
Hazardous substances	✅
Fuel consumption and efficiency	❌
Water consumption and efficiency	✅

Social

Percentage of female employees	—
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	❌
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Governance (Corporate Governance)

Environmental reporting	✅
Stakeholder Engagement	❌
Call Back Policies	❌
Antitrust law	❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Daan Gene Co list of shareholders

%	Name	Stocks	Change	Date
5.11784 %	Guangzhou Finance Holdings Group Co., Ltd.	70,172,302	0	12/31/2023
2.11208 %	Hwabao WP Fund Management Co., Ltd.	28,959,417	-973,920	12/31/2023
17.02187 %	Guangzhou Guangyong Technology Development Co., Ltd.	233,391,995	0	12/31/2023
10.23569 %	Guangzhou Biotechnology Center Co., Ltd.	140,344,607	0	12/31/2023
1.85859 %	He (Yun Shao)	25,483,707	0	12/31/2023
0.93484 %	Central Huijin Asset Management Co., Ltd.	12,817,911	0	12/31/2023
0.48036 %	GF Fund Management Co., Ltd.	6,586,323	1,998,000	12/31/2023
0.38875 %	China Southern Asset Management Co. Ltd.	5,330,308	-2,273,740	12/31/2023
0.38706 %	China Merchants Fund Management Co. Ltd.	5,307,060	4,800,020	12/31/2023
0.38399 %	Ping An Life Insurance Company of China, Ltd	5,265,000	5,265,000	12/31/2023
0.28630 %	China Universal Asset Management Co., Ltd.	3,925,545	-488,654	12/31/2023
0.24989 %	E Fund Management Co. Ltd.	3,426,324	130,951	6/30/2023
0.23791 %	Maxwealth Fund Management Co., Ltd.	3,262,111	219,300	6/30/2023
0.21182 %	The Vanguard Group, Inc.	2,904,307	71,100	3/31/2024
0.19112 %	Fullgoal Fund Management Co., Ltd.	2,620,491	-6,660	12/31/2023
0.15855 %	Ping An Fund Management Company Limited	2,173,896	-300	12/31/2023
0.15521 %	Dimensional Fund Advisors, L.P.	2,128,073	0	3/31/2024
0.10616 %	China Asset Management Co., Ltd.	1,455,585	266,800	12/31/2023
0.09711 %	Harvest Fund Management Co., Ltd.	1,331,490	1,100	12/31/2023
0.07924 %	INVESCO Great Wall Fund Management Co. Ltd.	1,086,450	-2,476	12/31/2023
0.05547 %	State Street Global Advisors (US)	760,596	-17,500	3/31/2024
0.04896 %	Zhong Ou Asset Management Co., Ltd.	671,303	671,303	12/31/2023
0.03235 %	Huatai-PineBridge Fund Management Co., Ltd.	443,520	-101,100	6/30/2023
0.02960 %	Bosera Asset Management Co., Ltd.	405,919	-63,540	12/31/2023
0.02801 %	Premia Partners Company Limited	384,116	53,980	3/31/2024
0.02747 %	Penghua Fund Management Co., Ltd.	376,635	155,900	6/30/2023
0.02567 %	Allianz Global Investors GmbH	351,916	0	2/29/2024
0.02514 %	Chang Xin Asset Management Co., Ltd.	344,714	-225,486	12/31/2023
0.02250 %	Vestcor Inc	308,455	162,895	12/31/2022
0.02036 %	Dimensional Fund Advisors, Ltd.	279,156	0	2/29/2024
0.01728 %	Robeco Institutional Asset Management B.V.	236,900	0	2/29/2024
0.01506 %	AXA Investment Managers UK Ltd.	206,536	0	1/31/2024
0.01446 %	Broad Asset Management Co., Ltd	198,300	198,300	12/31/2023
0.01311 %	CPIC Fund Management Co., Ltd.	179,740	12,300	6/30/2023
0.01292 %	Jupiter Asset Management Ltd.	177,200	177,200	4/30/2023
0.01269 %	Dacheng Fund Management Co., Ltd.	174,038	2,900	12/31/2023
0.01221 %	SWS MU Fund Management Co., Ltd.	167,365	-50,400	12/31/2023
0.01194 %	Allianz Global Investors U.S. LLC_NLE	163,716	0	10/31/2023
0.01142 %	CCB Principal Asset Management Co., Ltd.	156,532	-2,100	12/31/2023
0.01051 %	State Street Global Advisors (UK) Ltd.	144,118	0	3/31/2024
0.01022 %	Charles Schwab Investment Management, Inc.	140,160	0	3/31/2024
0.00987 %	Northern Trust Global Investments Limited	135,326	0	12/31/2023
0.00672 %	Minsheng Royal Fund Management Company Ltd.	92,200	28,100	6/30/2023
0.00653 %	Yinhua Fund Management Co., Ltd.	89,544	-13,078	12/31/2023
0.00630 %	Nuode Asset Management Company Limited	86,400	86,400	6/30/2023
0.00625 %	Taikang Asset Management Co., Ltd.	85,660	0	12/31/2023
0.00595 %	JPMorgan Asset Management (China) Company Limited.	81,528	-6,000	6/30/2023
0.00583 %	BlackRock Investment Management (UK) Ltd.	79,900	0	11/30/2023
0.00575 %	HuaAn Fund Management Co., Ltd.	78,860	-210,200	12/31/2023
0.00515 %	Florida State Board of Administration	70,600	70,600	9/30/2022
0.00481 %	Arrowstreet Capital, Limited Partnership	65,900	65,900	12/31/2023
0.00272 %	ICBC Credit Suisse Asset Management Co. Ltd.	37,252	-19,016	12/31/2023
0.00269 %	Goldman Sachs Asset Management B.V.	36,900	0	10/31/2023
0.00258 %	BlackRock Asset Management North Asia Limited	35,378	3,394	1/31/2023
0.00253 %	Legal & General Investment Management Ltd.	34,720	0	2/29/2024
0.00241 %	Founder Fubon Fund Management Co., Ltd.	33,000	-100	12/31/2023
0.00238 %	Tibet Eastmoney Fund Management Co., Ltd.	32,640	-300	6/30/2023
0.00223 %	Macquarie Investment Management Global Ltd.	30,563	30,563	12/31/2023
0.00216 %	Van Eck Associates Corporation	29,600	-20,900	8/31/2023
0.00205 %	Mirae Asset Global Investments (Hong Kong) Limited	28,100	-2,446	9/30/2023
0.00191 %	China Life AMP Asset Management Co., Ltd	26,244	-1,000	12/31/2023
0.00187 %	Mirae Asset Global Investments (USA) LLC	25,580	-4,400	12/31/2023
0.00181 %	Harvest Global Investments Limited	24,818	0	2/29/2024
0.00178 %	Assenagon Asset Management S.A.	24,369	-1,340	11/30/2023
0.00153 %	Franklin Advisers, Inc.	21,000	3,800	3/31/2024
0.00141 %	BOCI-Prudential Asset Management Ltd.	19,400	19,400	9/30/2023
0.00101 %	CITIC Prudential Fund Management Co., Ltd.	13,860	-22,700	6/30/2023
0.00098 %	Manulife Fund Management Co., Ltd.	13,500	-47,000	6/30/2023
0.00094 %	Galaxy Asset Management Co., Ltd.	12,900	12,900	12/31/2023
0.00093 %	Huatai Securities (Shanghai) Asset Management Co., Ltd.	12,800	1,900	6/30/2023
0.00093 %	Zheshang Fund Management Co., Ltd.	12,700	5,500	12/31/2023
0.00076 %	DFA Australia Ltd.	10,441	-74	12/31/2023
0.00070 %	Zhongtai Securities (Shanghai) Asset Management Co., Ltd.	9,600	600	6/30/2023
0.00070 %	BOC International (China) Ltd.	9,560	500	12/31/2023
0.00068 %	Vanguard Investments Australia Ltd.	9,345	682	2/29/2024
0.00067 %	JPMorgan Asset Management (Asia Pacific) Limited	9,185	-50	6/30/2023
0.00059 %	Morgan Stanley Investment Management (China) Company Limited.	8,100	8,100	12/31/2023
0.00057 %	ABC-CA Fund Management Co., Ltd.	7,788	-400	12/31/2023
0.00052 %	Fubon Asset Management Company Ltd.	7,152	0	2/29/2024
0.00052 %	BlackRock Institutional Trust Company, N.A.	7,114	-93,110	9/30/2023
0.00048 %	Vanguard Global Advisers LLC	6,520	0	2/29/2024
0.00041 %	Franklin Advisory Services, LLC	5,640	88	3/31/2024
0.00039 %	Shanghai Haitong Securities Asset Management Ltd.	5,400	-4,800	6/30/2023
0.00039 %	PICC Asset Management Company Limited	5,373	-900	6/30/2023
0.00036 %	CICC Fund Management Co Ltd.	4,900	-3,000	12/31/2023
0.00034 %	Western Leadbank Fund Management Co., Ltd.	4,700	4,700	12/31/2023
0.00034 %	Northern Trust Investments, Inc.	4,700	0	3/31/2024
0.00034 %	First Seafront Fund Management Co., Ltd.	4,621	-2,480	12/31/2023
0.00032 %	ZhongRong Fund Mgmt Co., Ltd	4,456	-500	6/30/2023
0.00031 %	Zhong Hai Fund Management Co., Ltd.	4,256	4,256	12/31/2023
0.00027 %	CIB Fund Management Co., Ltd.	3,760	-3,900	12/31/2023
0.00024 %	Lincoln Investment Advisors Corporation	3,356	0	3/31/2023
0.00023 %	Changsheng Fund Management Co., Ltd.	3,201	-300	12/31/2023
0.00020 %	Orient Fund Management Co. Ltd.	2,700	2,700	6/30/2023
0.00019 %	HSBC Global Asset Management (UK) Limited	2,668	0	12/31/2023
0.00018 %	Allianz Global Investors Japan Co., Ltd.	2,400	0	6/30/2023
0.00016 %	Cinda Fund Management Co., Ltd.	2,200	2,200	12/31/2022
0.00015 %	Asset Management One Co., Ltd.	2,118	13	12/31/2022
0.00012 %	Essence Fund Management Co., Ltd.	1,700	1,700	12/31/2023
0.00012 %	Bank of China Investment Management Co., Ltd.	1,640	0	12/31/2023

...

Most common questions regarding Daan Gene Co

What is the P/E ratio of Daan Gene Co 2024?

The P/E ratio cannot be calculated for Daan Gene Co at the moment.

What is the P/S ratio of Daan Gene Co 2024?

The P/S cannot be calculated for Daan Gene Co currently.

What is the AlleAktien quality score of Daan Gene Co?

The AlleAktien quality score for Daan Gene Co is 3/10.

What is the revenue of Daan Gene Co 2024?

The revenue cannot currently be calculated for Daan Gene Co.

How high is the profit of Daan Gene Co 2024?

The profit cannot currently be calculated for Daan Gene Co.

What is the business model of Daan Gene Co

No history available for Daan Gene Co.

What is the Daan Gene Co dividend?

Daan Gene Co pays a dividend of 1.11 CNY distributed over payouts per year.

How often does Daan Gene Co pay dividends?

The dividend cannot currently be calculated for Daan Gene Co or the company does not pay out a dividend.

What is the Daan Gene Co ISIN?

The ISIN of Daan Gene Co is CNE000001KP1.

What is the Daan Gene Co ticker?

The ticker of Daan Gene Co is 002030.SZ.

How much dividend does Daan Gene Co pay?

Over the past 12 months, Daan Gene Co paid a dividend of 1.75 CNY . This corresponds to a dividend yield of about 32.83 %. For the coming 12 months, Daan Gene Co is expected to pay a dividend of 1.75 CNY.

What is the dividend yield of Daan Gene Co?

The current dividend yield of Daan Gene Co is 32.83 %.

When does Daan Gene Co pay dividends?

Daan Gene Co pays a quarterly dividend. This is distributed in the months of June, June, July, July.

How secure is the dividend of Daan Gene Co?

Daan Gene Co paid dividends every year for the past 19 years.

What is the dividend of Daan Gene Co?

For the upcoming 12 months, dividends amounting to 1.75 CNY are expected. This corresponds to a dividend yield of 32.83 %.

In which sector is Daan Gene Co located?

Daan Gene Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Daan Gene Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Daan Gene Co from 6/14/2024 amounting to 0.015 CNY, you needed to have the stock in your portfolio before the ex-date on 6/14/2024.

When did Daan Gene Co pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of Daan Gene Co in the year 2023?

In the year 2023, Daan Gene Co distributed 1.11 CNY as dividends.

In which currency does Daan Gene Co pay out the dividend?

The dividends of Daan Gene Co are distributed in CNY.

Daan Gene Co stock price, news, forecast, analysis

Sector

Health

Industry

Biotechnology

Number of shares

1,371,130,000

Employee

3,580

Revenue growth Ø5 years

1.46 %

EBIT growth Ø5 years

44.88 %

Net Income growth Ø5 years

2.57 %

Website Daan Gene Co

Country

People's Republic of China 🇨🇳

Currency

CNY

Initial public offering

Aug 9, 2004

GOSIN

Global Open Securities Identification Number

Cusip

Y1856D115

Market capitalization

7.05 B

Daan Gene Co Directors Dealings

AAQS

Details

3 / 10

PEG

P/E

Forward P/E

P/S

Forward P/S

ROE (Return on Equity)

1.18 %

ROA (Return on Assets)

0.95 %

ROCE (Return on Capital Employed)

-2.99 %

ROIC

-15.22 %

Dividend

1.75 undefined

Dividend yield

32.83 %

Dividend growth Ø5Y

137.21 %

Dividends per year

Paid since

19 years

Not cut since

3 years

Increased since

3 years

Dividends tax

25.83 %

Scalable Capital savings plan

Nein

Trade Republic savings plan

Nein

comdirect savings plan

Consorsbank savings plan

Nein

ING savings plan

Nein

Daan Gene Co Peer Group

Daan Gene Co Eulerpool News

Daan Gene Co News

All Daan Gene Co News

Daan Gene Co Ticker

Stock Exchange	Daan Gene Co Ticker
SHZ	002030.SZ

Daan Gene Co FIGI

Daan Gene Co Ticker	Daan Gene Co FIGI
002030:CH	BBG000Q51MT8
002030:CS	BBG000Q51NH9
002030:C2	BBG00F136VG6

All fundamentals about Daan Gene Co

Our stock analysis for Daan Gene Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Daan Gene Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-9	-20	-36	-31	-36	-25	-48	-28	-25	-51	-291	-314	-299	-340	-903	-849	-215	-427	-685	-853	-1,623
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-10	-13	-18	-19	-16	-27	-37	-38	-27	-36	-41	-39	-88	-61	-60	-71	-72	-63	-364	-754	-1,503
0.01	0.02	0.02	0.03	0.03	0.01	0.03	0.05	0.08	0.06	0	0.03	0.04	-0.01	-0.38	-0.22	0.39	0.09	2.51	3.3	4.15
-25	-32	-31	-14	-51	-83	-25	-40	-40	-62	-71	-73	-77	-154	-221	-191	-100	-93	-364	-658	-1,502
-19	-32	-28	-14	-50	-104	-30	-47	-48	-78	-43	24	-81	-248	-281	-233	-825	-121	-1,175	-1,379	-1,959
6	0	2	0	1	-20	-4	-7	-8	-15	28	97	-4	-93	-60	-42	-725	-27	-811	-720	-457
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
5	15	-15	-35	0	64	35	-10	-10	5	55	5	129	372	557	74	-151	-24	-587	-114	-159
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.01	0.13	-0.05	-0.02	0.05	0.06	-0.02	-0.02	-0	0.04	-0.01	0.09	1.24	0.97	0.21	-0.39	-0.13	-0.69	-0.63	-1.79
0	0	153	2	0	0	54	0	1	0	0	0	-16	918	476	231	-131	-10	-38	-16	-65
-3	-1	-11	-12	-15	-12	-27	-8	-10	-8	-15	-16	-25	-51	-61	-95	-103	-96	-59	-496	-1,569
0.03	0.06	0.18	0.05	0.05	0.02	0.18	0.11	0.14	0.14	0.34	0.42	0.47	1.38	0.89	0.46	-0.14	0.43	4.21	6.21	7.71
-13.5	-9.6	-15.8	13.6	-21	-74.8	3.9	14.1	38.9	1.9	-68.2	-46.2	-37.2	-160	-602.3	-411.3	292	-0.3	2,149.7	2,645.8	2,652.21
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

Ticker002030.SZ

ISINCNE000001KP1

Daan Gene Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Daan Gene Co Stock Price History

Daan Gene Co Revenue, EBIT, Net Income CNE000001KP1 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Daan Gene Co Revenue, EBIT and net profit per share

Daan Gene Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Daan Gene Co stock margins CNE000001KP1 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Daan Gene Co Margin History

Daan Gene Co Stock Sales Revenue, EBIT, Earnings per Share CNE000001KP1 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Daan Gene Co Revenue, EBIT and net profit per share

Daan Gene Co business model

Daan Gene Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Daan Gene Co historical P/E ratio, EBIT, and P/S ratio.

Daan Gene Co shares outstanding CNE000001KP1 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Daan Gene Co Stock splits

Daan Gene Co dividend history and estimates CNE000001KP1 ·

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Daan Gene Co Dividend History

Daan Gene Co dividend payout ratio CNE000001KP1 ·

Payout ratio

What is Yearly Payout Ratio?

How to Interpret the Data

Using the Data for Investments

Daan Gene Co Payout Ratio History

Daan Gene Co Earnings Estimates

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
002030.SZ

ISIN
CNE000001KP1